Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126192511 | 12619251 | 1 | I | 20140514 | 20160729 | 20160803 | 20160803 | EXP | US-PFIZER INC-2016370117 | PFIZER | 0.00 | A | M | Y | 0.00000 | 20160803 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126192511 | 12619251 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | UNK | 20895 | FILM-COATED TABLET | |||||||||
| 126192511 | 12619251 | 2 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | UNK | 20895 | FILM-COATED TABLET | |||||||||
| 126192511 | 12619251 | 3 | SS | CIALIS | TADALAFIL | 1 | Oral | UNK, REGULARLY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126192511 | 12619251 | 1 | Erectile dysfunction |
| 126192511 | 12619251 | 3 | Erectile dysfunction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126192511 | 12619251 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126192511 | 12619251 | Malignant melanoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126192511 | 12619251 | 1 | 200803 | 201106 | 0 | |
| 126192511 | 12619251 | 2 | 201308 | 201308 | 0 | |
| 126192511 | 12619251 | 3 | 201201 | 201307 | 0 |